Literature DB >> 32908820

Severe Refractory Anaemia and Fever of Unknow Origin: Human Parvovirus B19 Reactivation.

Joaquín Escobar-Sevilla1, Antonio Bustos Merlo1, Carmen Garcia Martínez1, Juan Diego Mediavilla Garcia1.   

Abstract

Reactivation of human parvovirus B19 is exceptional and characteristic of immunosuppression, with anaemia being the predominant manifestation although pancytopenia and thrombotic microangiopathy may also occur. We describe a patient with a history of diffuse large B-cell lymphoma with pure erythrocyte aplasia due to reactivation of parvovirus B19, who was treated with corticosteroids and immunoglobulins. LEARNING POINTS: Infection with human parvovirus B19 is identified by polymerase chain reaction (PCR) testing of blood and the presence of typical giant proerythroblasts in the bone marrow.Cytomegalovirus infection should be considered in immunosuppressed patients with fever and non-specific symptoms with haematological changes.The treatment of persistent infection in immunosuppressed patients is based on the administration of IV immunoglobulins at high doses. © EFIM 2020.

Entities:  

Keywords:  Human parvovirus B19; pure red cell aplasia; viral reactivation

Year:  2020        PMID: 32908820      PMCID: PMC7473696          DOI: 10.12890/2020_001596

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  19 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

Review 2.  Parvovirus B19 infection after transplantation: a review of 98 cases.

Authors:  Albert J Eid; Robert A Brown; Robin Patel; Raymund R Razonable
Journal:  Clin Infect Dis       Date:  2006-05-12       Impact factor: 9.079

3.  Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825).

Authors:  Ricardo García-Muñoz; Alicia Galar; Cristina Moreno; Paula Rodríguez-Otero; Elena Panizo-Morgado; Mariano Ponz-Sarvisê; Mirian Fernandez-Alonso; Manuel Rubio; Juana Merino; Braulia Cuesta; Carlos Panizol; Felipe Prosper
Journal:  Leuk Lymphoma       Date:  2007-12

4.  Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.

Authors:  Annelie Plentz; Michael Würdinger; Matthias Kudlich; Susanne Modrow
Journal:  J Clin Virol       Date:  2013-07-31       Impact factor: 3.168

5.  Human parvovirus B19 in solid organ transplantation.

Authors:  A J Eid; S F Chen
Journal:  Am J Transplant       Date:  2013-03       Impact factor: 8.086

6.  Parvovirus B19 in kidney transplant patients.

Authors:  Z R Zolnourian; M D Curran; B K Rima; P V Coyle; H J O'Neill; D Middleton
Journal:  Transplantation       Date:  2000-05-27       Impact factor: 4.939

7.  Parvovirus B19-Associated Anemia in Kidney Transplant Recipients: A Single-Center Experience.

Authors:  Ha Phan Hai An; Hoang Thi Diem; Nguyen The Cuong
Journal:  Transplant Proc       Date:  2019-07-24       Impact factor: 1.066

Review 8.  How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?

Authors:  C Gosset; D Viglietti; K Hue; C Antoine; D Glotz; E Pillebout
Journal:  Transpl Infect Dis       Date:  2012-08-30       Impact factor: 2.228

9.  Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation.

Authors:  Roseline Porignaux; Vincent Vuiblet; Coralie Barbe; Yohan Nguyen; Sylvie Lavaud; Olivier Toupance; Laurent Andréoletti; Philippe Rieu; Nicolas Lévêque
Journal:  J Med Virol       Date:  2013-06       Impact factor: 2.327

Review 10.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.